Search clinical trials for: Metformin Rosuvastatin

Total 2800 results

Bethesda Diabetes Research Center
University Medical Center Groningen; Maastricht University Medical Center; Medical... and other collaborators

Recruiting

Pregnancy Outcomes: Effects of Metformin Study (POEM Study) (POEM)

Insulin Resistance | Gestational Diabetes

Netherlands
Chang Gung Memorial Hospital

Unknown

Gut Microbiota and Bile Acids in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Metformin | YH1

Taiwan
GlaxoSmithKline

Completed

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Canada
Hospices Civils de Lyon

Unknown

Metformin Use in Chronic Kidney Disease: The CKD-Met Study (CKD-Met)

Type 2 Diabetes | Chronic Kidney Disease

France
Assiut University

Not yet recruiting

Effect of Rosuvastatin on the Clinical Features of Preeclampsia

Preeclampsia
AstraZeneca

Withdrawn

Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

PCI Patients
Tokyo Medical University

Unknown

Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography

Intracranial Arterial Diseases

Japan
Shenyang Northern Hospital

Completed

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes (TRACK-D)

Diabetes Mellitus | Chronic Kidney Disease

China
AstraZeneca

Completed

Rosuvastatin ORBITAL Germany

Hypercholesterolemia
AstraZeneca

Completed

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Metabolic Syndrome | Dyslipidemia

Australia
University of Leipzig
AstraZeneca

Completed

Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure

Heart Failure

Germany
Hospital Pedro Hispano
Northwestern University

Completed

Rosuvastatin Affecting Aortic Valve Endothelium

Atherosclerosis | Hypercholesterolemia

Portugal
Rutgers University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome

Metabolic Syndrome

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects

Healthy

Germany
Laboratorios Silanes S.A. de C.V.

Completed

Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

Healthy

Mexico
Severance Hospital

Completed

Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

Healthy

Korea, Republic of
Elpen Pharmaceutical Co. Inc.

Completed

PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT (PLATINUM)

Quality of Life | Dyslipidemias | Hyperlipidemias | Risk Factor, Cardiovascular

Greece
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

Blood Pressure | Renal Artery Obstruction | Glomerular Filtration Rate | Stents | Lipids

China
Second Affiliated Hospital of Soochow University
National Natural Science Foundation of China; AstraZeneca; Taicang No.1 People...

Unknown

Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) (REPAIRS)

Infarction, Anterior Cerebral Artery

China
UMC Utrecht

Withdrawn

Rosuvastatin for Hepatitis C

Hepatitis C

Netherlands
General University Hospital, Prague
University of Iowa; Loyola University Chicago; Ministry of Health, Czech Republic and other collaborators

Unknown

The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques (PREDICT)

Coronary Artery Disease

United States, Czech Republic
Seoul National University Hospital
Gangnam Severance Hospital

Recruiting

Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia (REMBRANDT)

Diabetes Mellitus, Type 2 | Endocrine System Diseases | Dyslipidemias | Nutritional and Metabolic Diseases

Korea, Republic of
Nanjing First Hospital, Nanjing Medical University

Unknown

Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin (CROWN-1)

Acute Coronary Syndrome

China
Centre de Recherche de l'Institut Universitaire...

Completed

Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects (SPICE)

Coronary Artery Disease

Canada
Yonsei University

Not yet recruiting

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Peripheral Artery Disease | Polyvascular Disease

Korea, Republic of
Saint Vincent's Hospital, Korea

Recruiting

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention (ALMIGHTY)

Coronary Artery Disease | Dyslipidemias | Primary Prevention

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Healthy

United States
Bangabandhu Sheikh Mujib Medical University, Dhaka...
Department of Genetic Engineering and Biotechnology, Dhaka University

Recruiting

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

Polycystic Ovary Syndrome | Metformin

Bangladesh
Istituto Ortopedico Rizzoli

Recruiting

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse (Metform-Bone)

Osteosarcoma | Ewing Sarcoma

Italy
Cairo University

Completed

Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients

Heart Failure

Egypt
Kyongtae Ty Bae, M.D., Ph.D.
University of Maryland, Baltimore; United States Department of Defense; University... and other collaborators

Completed

Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (TAME)

Polycystic Kidney, Autosomal Dominant

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM

Type 2 Diabetes Mellitus

China
National Center of Cardiology and Internal Medicine...

Completed

The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes

Coronary Artery Disease | PreDiabetes | Chronic Heart Failure

Kyrgyzstan
Shenzhen People's Hospital

Completed

Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes

China
Chongqing Medical University

Completed

Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes (CQM-2016)

Diabetes Mellitus

China
British Columbia Cancer Agency
BC Cancer Foundation; Pancreatic Cancer Canada

Unknown

The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma (Metformin 001)

Resectable Pancreatic Ductal Adenocarcinoma

Canada
Takeda

Terminated

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

Diabetes Mellitus
GlaxoSmithKline

Completed

A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin

Diabetes Mellitus, Type 2

United States, Taiwan, Argentina, Canada, Philippines, Korea, Republic of, Mexico, Brazil, Pakistan
Laboratorios Silanes S.A. de C.V.

Recruiting

Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure

Type 2 Diabetes

Mexico
Wake Forest University Health Sciences
University of South Florida; National Institute on Aging (NIA)

Recruiting

Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction (Met-PEF)

Heart Failure With Preserved Ejection Fraction

United States
PT. Pyridam Farma Tbk
PT Pharma Metric Labs

Completed

Bioequivalence Study of Metformin Hydrochloride 500 mg Film-Coated Tablets in Indonesia Healthy Subject

Drug Use

Indonesia
Sunovion

Completed

A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

Schizophrenia

United States
Hager salah el din

Completed

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Metastatic Breast Cancer

Egypt
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Diabetes Mellitus, Type II
Kristian Karstoft
University of Copenhagen

Completed

The Interaction Between Metformin and Acute Exercise

Diabetes Mellitus, Type 2 | Impaired Glucose Tolerance

Denmark
National Cheng-Kung University Hospital

Terminated

Metformin in Stage IV Lung Adenocarcinoma

Non-small Cell Lung Cancer

Taiwan
GlaxoSmithKline

Completed

Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.

Diabetes Mellitus, Type 2

Spain, Germany, France, Austria, Italy
K. Marcinkowski University of Medical Sciences

Completed

Metformin in Gestational Diabetes Mellitus (MetGDM)

Insulin Resistance | Diabetes, Gestational

Poland
University of Oulu
University of Turku; University of Helsinki; Tampere University; University of...

Completed

The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)

Toxemia | Polycystic Ovary Syndrome | Infertility | Miscarriage | Gestational Diabetes

Finland

Search clinical trials for: Metformin Rosuvastatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations